All Releases
 |
2012 PPD Beach2Battleship Triathlon Heroes Deliver Message of Bringing Life-Changing Medical Treatments to People in Need
Sep 26, 2012
|
18.3 KB |
| |
WILMINGTON, N.C., (September 26, 2012) - Pharmaceutical Product Development, LLC (PPD) today announced the 2012 team of inspirational athletes serving as PPD Heroes and competing in the PPD Beach...
|
|
PPD and Global Allergy and Asthma European Network (GA2LEN) Announce Strategic Alliance in Allergic Diseases
Sep 13, 2012
|
14.3 KB |
| |
WILMINGTON, N.C., and BERLIN, GERMANY (September 13, 2012) - Pharmaceutical Product Development, LLC (PPD) and the Global Allergy and Asthma European Network e.V. (GA2LEN) today announced a strategic alliance in which GA2LEN will provide PPD access to the network's allergy and asthma experts and to more than 100 alle...
|
|
PPD Named to InformationWeek 500 List of Top Business Technology Innovators
Sep 12, 2012
|
15.5 KB |
| |
WILMINGTON, N.C. (September 12, 2012) - Pharmaceutical Product Development, LLC (PPD) today announced it has been named to the 2012 InformationWeek 500, an annual recognition of the most innovative users of business technology in the United States. PPD was selected for its commitment to industry-leading ...
|
|
PPD's Lee Babiss Recognized for Innovation in CRO Services
Aug 1, 2012
|
15.5 KB |
| |
WILMINGTON, N.C., (August 1, 2012) - Pharmaceutical Product Development, LLC (PPD) today announced that Lee Babiss, Ph.D., chief scientific officer and executive vice president of global laboratory services, has been named to the 2012 PharmaVOICE 100 list ...
|
|
PPD Earns Highest Ratings for Customer Loyalty and Overall Value Among Phase I Providers in ISR Report
Jul 31, 2012
|
13.7 KB |
| |
WILMINGTON, N.C. (July 31, 2012) - Pharmaceutical Product Development, LLC (PPD) has earned the highest ratings in customer loyalty, overall value and several other attributes for Phase I services according to an Industry Standard Research (ISR) study, which evaluated...
|
|
PPD Names Louis Renzetti, Ph.D., Vice President of Strategic Laboratory Operations
Jul 17, 2012
|
121.0 KB |
| |
WILMINGTON, N.C., (July 17, 2012) - Pharmaceutical Product Development, LLC (PPD) today announced the appointment of Louis Renzetti, Ph.D., as vice president of strategic laboratory operations.
"Lou brings strong pharmaceutical expertise to help us build and strengthen our strategic lab partnerships with pharma, biotech, academia...
|
|
PPD Names David Simmons Chairman and CEO
May 23, 2012
|
14.0 KB |
| |
WILMINGTON, N.C., (May 23, 2012) - Pharmaceutical Product Development, LLC (PPD) today announced that its board of directors has named David Simmons chairman and CEO. Mr. Simmons, an experienced pharmaceutical industry executive, joins PPD from Pfizer Inc., where he served as president and general manager of the emerging markets and estab...
|
|
PPD Scientist Recognized for Contributions in Clinical Research
Mar 5, 2012
|
8.2 KB |
| |
WILMINGTON, N.C. (December 12, 2007) - PPD, Inc. (Nasdaq: PPDI) today announced the appointment of Philip Mathew, M.D., as director of strategic development, to lead the company's Phase II-IV operations and expansion in India.
Dr. Mathew will provide strategic leadership for PPD's drug development business on the Indian subcontine...
|
|
PPD Recognized for Expertise in Clinical Research
Feb 20, 2012
|
14.2 KB |
| |
WILMINGTON, N.C., (February 20, 2012) - Demonstrating its expertise in clinical research, Pharmaceutical Product Development, LLC (PPD) today announced that PharmaTimes magazine has named a team of PPD researchers the 2012 Clinical Team of the Year.
The honor...
|
|
PPD Recognized for Outstanding Employee Training and Development
Feb 14, 2012
|
16.2 KB |
| |
WILMINGTON, N.C., (February 14, 2012) - Highlighting its commitment to employees and clients, Pharmaceutical Product Development, LLC (PPD) today announced that Training magazine has named the global ...
|
|
Scottish Government and PPD Announce Strategic Alliance to Advance Clinical Research in Scotland
Feb 9, 2012
|
10.5 KB |
| |
EDINBURGH, SCOTLAND, and WILMINGTON, N.C., (February 9, 2012) - The Scottish government and Pharmaceutical Product Development, LLC (PPD) today announced a unique alliance designed to increase the amount of clinical research conducted in Scotland, accelerate the development of new medical therapies and enhance health care treatment option...
|
|
Dow AgroSciences, BioDuro to Collaborate on Crop Protection Discovery Research
Feb 7, 2012
|
13.0 KB |
| |
INDIANAPOLIS and WILMINGTON, N.C. - (February 7, 2012) - Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), and BioDuro, a PPD® Company, announced today a three-year, multi-program discovery research agreement to generate novel molecules for synthesizing and testing fungicides, insecticides...
|
|
PPD and VirtualScopics Expand Strategic Alliance for Medical Imaging Services
Jan 26, 2012
|
13.6 KB |
| |
WILMINGTON, N.C., and ROCHESTER, N.Y., (January 26, 2012) - Pharmaceutical Product Development, Inc. and VirtualScopics, Inc. (Nasdaq: VSCP) today announced they have expanded their successful one-year strategic alliance in clinical and medical imaging services across multiple therapeutic areas to now include oncology, central nerv...
|
|
The Carlyle Group and Hellman & Friedman Complete Acquisition of PPD
Dec 5, 2011
|
12.8 KB |
| |
WILMINGTON, N.C., (December 5, 2011) - Pharmaceutical Product Development, Inc. today announced the completion of its acquisition by affiliates of The Carlyle Group and affiliates of Hellman & Friedman in an all-cash transaction valued at approximately $3.9 billion.
As previously announced, the transaction was approved by PPD ...
|
|
PPD Announces Shareholder Approval of Merger with Affiliates of The Carlyle Group and Hellman & Friedman
Nov 30, 2011
|
9.5 KB |
| |
WILMINGTON, N.C., (November 30, 2011) - Pharmaceutical Product Development, Inc. (Nasdaq: PPDI) today announced that its shareholders have voted to approve the adoption of the agreement and plan of merger, dated October 2, 2011, providing for the merger of the company with an entity controlled by affiliates of The Carlyle Group and affili...
|
|
PPD Named Best Contract Research Organization and Honored for Best Technological Development in Clinical Trials by Scrip
Nov 4, 2011
|
15.2 KB |
| |
WILMINGTON, N.C., (November 4, 2011) - Pharmaceutical Product Development, Inc. (Nasdaq: PPDI) today announced it has been named the best contract research organization by Scrip Intelligence, which also has honored PPD for deploying the best technological development in clinical trials.
Scrip presented both awards to...
|
|
PPD Declares Fourth Quarter Dividend
Nov 2, 2011
|
9.6 KB |
| |
WILMINGTON, N.C. (November 2, 2011) - Pharmaceutical Product Development, Inc. (Nasdaq: PPDI) today announced that its board of directors declared a cash dividend for the fourth quarter of 2011 under its annual cash dividend policy. The quarterly cash dividend will equal $0.15 per share. The record date for the fourth quarter dividend is ...
|
|
PPD Announces End of "Go-Shop" Period and Early Termination of Hart-Scott-Rodino Waiting Period
Nov 2, 2011
|
12.1 KB |
| |
WILMINGTON, N.C. (November 2, 2011) - Pharmaceutical Product Development, Inc. (Nasdaq: PPDI) today announced the expiration of the 30-day "go-shop" period pursuant to the terms of the previously announced definitive merger agreement, entered into on October 2, 2011, between PPD and affiliates of The Carlyle Group and affiliates of Hellma...
|
|
PPD Announces 2011 PPD Beach2Battleship Triathlon Heroes
Oct 13, 2011
|
15.6 KB |
| |
WILMINGTON, N.C., (October 13, 2011) - PPD, Inc. (Nasdaq: PPDI) today announced the 2011 PPD Heroes team, featuring cancer survivors and medical specialists competing as triathletes in the PPD Beach2Battleship Triathlon on Oct. 29. The PPD Heroes are helping raise public awareness about the value of participating in clinical trials in the...
|
|
PPD to be Acquired by The Carlyle Group and Hellman & Friedman
Oct 3, 2011
|
17.3 KB |
| |
PPD shareholders to receive $33.25 per share in cash
Transaction value is approximately $3.9 billion
PPD to become a privately held company
WILMINGTON, N.C. (October 3, 2011) - Pharmaceutical Product Development, Inc. (Nasdaq: PPDI) today announced that it has entered into a de...
|
|
|
